APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cabozantinib Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cabozantinib Tablets Industry Growth and Trends Forecast to 2032

27 December 202573 pages

Choose your research edition.

Industry ResearchCabozantinib Tablets Industry Research Report 2026105 pages · $2,950 USDIndustry Growth & TrendsGlobal Cabozantinib Tablets Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Cabozantinib Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032178 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cabozantinib Tablets Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cabozantinib Tablets Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Cabozantinib Tablets market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cabozantinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cabozantinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cabozantinib Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cabozantinib Tablets include Cipla, Natco Pharma, Exelixis and Drug International, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cabozantinib Tablets market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cabozantinib Tablets market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cabozantinib Tablets market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cabozantinib Tablets.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cabozantinib Tablets market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cabozantinib Tablets Market by Company

Cipla

Natco Pharma

Exelixis

Drug International

Cabozantinib Tablets Segment by Type

60mg per Tablet

40mg per Tablet

20mg per Tablet

Cabozantinib Tablets Segment by Application

Medullary Thyroid Cancer

Renal Cell Carcinoma

Hepatocellular Carcinoma

Cabozantinib Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cabozantinib Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cabozantinib Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cabozantinib Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cabozantinib Tablets manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cabozantinib Tablets in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 60mg per Tablet Table 2. Major Company of 40mg per Tablet Table 3. Major Company of 20mg per Tablet Table 4. Global Cabozantinib Tablets Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Cabozantinib Tablets Sales by Type (2021-2026) & (K Units) Table 6. Global Cabozantinib Tablets Sales Market Share in Volume by Type (2021-2026) Table 7. Global Cabozantinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 8. Global Cabozantinib Tablets Sales Market Share in Value by Type (2021-2026) Table 9. Global Cabozantinib Tablets Price by Type (2021-2026) & (US$/Unit) Table 10. Global Cabozantinib Tablets Sales by Type (2027-2032) & (K Units) Table 11. Global Cabozantinib Tablets Sales Market Share in Volume by Type (2027-2032) Table 12. Global Cabozantinib Tablets Sales by Type (2027-2032) & (US$ Million) Table 13. Global Cabozantinib Tablets Sales Market Share in Value by Type (2027-2032) Table 14. Global Cabozantinib Tablets Price by Type (2027-2032) & (US$/Unit) Table 15. North America Cabozantinib Tablets Sales by Type (2021-2026) & (K Units) Table 16. North America Cabozantinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Cabozantinib Tablets Sales by Type (2021-2026) & (K Units) Table 18. Europe Cabozantinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Cabozantinib Tablets Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Cabozantinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Cabozantinib Tablets Sales by Type (2021-2026) & (K Units) Table 22. Latin America Cabozantinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Cabozantinib Tablets Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Cabozantinib Tablets Sales by Type (2021-2026) & (US$ Million) Table 25. Cabozantinib Tablets Industry Trends Table 26. Cabozantinib Tablets Industry Drivers Table 27. Cabozantinib Tablets Industry Opportunities and Challenges Table 28. Cabozantinib Tablets Industry Restraints Table 29. Global Cabozantinib Tablets Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Cabozantinib Tablets Revenue Market Share by Company (2021-2026) Table 31. Global Cabozantinib Tablets Sales by Company (2021-2026) & (K Units) Table 32. Global Cabozantinib Tablets Sales Share by Company (2021-2026) Table 33. Global Cabozantinib Tablets Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Cabozantinib Tablets Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Cabozantinib Tablets Major Company Production Sites and Headquarters Table 36. Global Cabozantinib Tablets Company, Product Type & Application Table 37. Global Cabozantinib Tablets Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Cabozantinib Tablets by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Cabozantinib Tablets Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Cabozantinib Tablets Sales by Region (2021-2026) & (K Units) Table 42. Global Cabozantinib Tablets Sales Market Share in Volume by Region (2021-2026) Table 43. Global Cabozantinib Tablets Sales by Region (2021-2026) & (US$ Million) Table 44. Global Cabozantinib Tablets Sales Market Share in Value by Region (2021-2026) Table 45. Global Cabozantinib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Cabozantinib Tablets Sales by Region (2027-2032) & (K Units) Table 47. Global Cabozantinib Tablets Sales Market Share in Volume by Region (2027-2032) Table 48. Global Cabozantinib Tablets Sales by Region (2027-2032) & (US$ Million) Table 49. Global Cabozantinib Tablets Sales Market Share in Value by Region (2027-2032) Table 50. Global Cabozantinib Tablets Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Cabozantinib Tablets Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Cabozantinib Tablets Sales by Application (2021-2026) & (K Units) Table 53. Global Cabozantinib Tablets Sales Market Share in Volume by Application (2021-2026) Table 54. Global Cabozantinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 55. Global Cabozantinib Tablets Sales Market Share in Value by Application (2021-2026) Table 56. Global Cabozantinib Tablets Price by Application (2021-2026) & (US$/Unit) Table 57. Global Cabozantinib Tablets Sales by Application (2027-2032) & (K Units) Table 58. Global Cabozantinib Tablets Sales Market Share in Volume by Application (2027-2032) Table 59. Global Cabozantinib Tablets Sales by Application (2027-2032) & (US$ Million) Table 60. Global Cabozantinib Tablets Sales Market Share in Value by Application (2027-2032) Table 61. Global Cabozantinib Tablets Price by Application (2027-2032) & (US$/Unit) Table 62. North America Cabozantinib Tablets Sales by Application (2021-2026) & (K Units) Table 63. North America Cabozantinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Cabozantinib Tablets Sales by Application (2021-2026) & (K Units) Table 65. Europe Cabozantinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Cabozantinib Tablets Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Cabozantinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Cabozantinib Tablets Sales by Application (2021-2026) & (K Units) Table 69. Latin America Cabozantinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Cabozantinib Tablets Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Cabozantinib Tablets Sales by Application (2021-2026) & (US$ Million) Table 72. Cipla Company Information Table 73. Cipla Business Overview Table 74. Cipla Cabozantinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Cipla Cabozantinib Tablets Product Portfolio Table 76. Cipla Recent Development Table 77. Natco Pharma Company Information Table 78. Natco Pharma Business Overview Table 79. Natco Pharma Cabozantinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Natco Pharma Cabozantinib Tablets Product Portfolio Table 81. Natco Pharma Recent Development Table 82. Exelixis Company Information Table 83. Exelixis Business Overview Table 84. Exelixis Cabozantinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Exelixis Cabozantinib Tablets Product Portfolio Table 86. Exelixis Recent Development Table 87. Drug International Company Information Table 88. Drug International Business Overview Table 89. Drug International Cabozantinib Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Drug International Cabozantinib Tablets Product Portfolio Table 91. Drug International Recent Development Table 92. North America Cabozantinib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 93. North America Cabozantinib Tablets Sales by Country (2021-2026) & (K Units) Table 94. North America Cabozantinib Tablets Sales Market Share by Country (2021-2026) Table 95. North America Cabozantinib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 96. North America Cabozantinib Tablets Sales Market Share Forecast by Country (2027-2032) Table 97. North America Cabozantinib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 98. North America Cabozantinib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 99. North America Cabozantinib Tablets Market Share by Country (2021-2026) Table 100. North America Cabozantinib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 101. North America Cabozantinib Tablets Market Share Forecast by Country (2027-2032) Table 102. Europe Cabozantinib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 103. Europe Cabozantinib Tablets Sales by Country (2021-2026) & (K Units) Table 104. Europe Cabozantinib Tablets Sales Market Share by Country (2021-2026) Table 105. Europe Cabozantinib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 106. Europe Cabozantinib Tablets Sales Market Share Forecast by Country (2027-2032) Table 107. Europe Cabozantinib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 108. Europe Cabozantinib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 109. Europe Cabozantinib Tablets Market Share by Country (2021-2026) Table 110. Europe Cabozantinib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 111. Europe Cabozantinib Tablets Market Share Forecast by Country (2027-2032) Table 112. Asia-Pacific Cabozantinib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 113. Asia-Pacific Cabozantinib Tablets Sales by Country (2021-2026) & (K Units) Table 114. Asia-Pacific Cabozantinib Tablets Sales Market Share by Country (2021-2026) Table 115. Asia-Pacific Cabozantinib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 116. Asia-Pacific Cabozantinib Tablets Sales Market Share Forecast by Country (2027-2032) Table 117. Asia-Pacific Cabozantinib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 118. Asia-Pacific Cabozantinib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 119. Asia-Pacific Cabozantinib Tablets Market Share by Country (2021-2026) Table 120. Asia-Pacific Cabozantinib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 121. Asia-Pacific Cabozantinib Tablets Market Share Forecast by Country (2027-2032) Table 122. Latin America Cabozantinib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. Latin America Cabozantinib Tablets Sales by Country (2021-2026) & (K Units) Table 124. Latin America Cabozantinib Tablets Sales Market Share by Country (2021-2026) Table 125. Latin America Cabozantinib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 126. Latin America Cabozantinib Tablets Sales Market Share Forecast by Country (2027-2032) Table 127. Latin America Cabozantinib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. Latin America Cabozantinib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 129. Latin America Cabozantinib Tablets Market Share by Country (2021-2026) Table 130. Latin America Cabozantinib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. Latin America Cabozantinib Tablets Market Share Forecast by Country (2027-2032) Table 132. Middle East and Africa Cabozantinib Tablets Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Middle East and Africa Cabozantinib Tablets Sales by Country (2021-2026) & (K Units) Table 134. Middle East and Africa Cabozantinib Tablets Sales Market Share by Country (2021-2026) Table 135. Middle East and Africa Cabozantinib Tablets Sales Forecast by Country (2027-2032) & (K Units) Table 136. Middle East and Africa Cabozantinib Tablets Sales Market Share Forecast by Country (2027-2032) Table 137. Middle East and Africa Cabozantinib Tablets Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Middle East and Africa Cabozantinib Tablets Market Size by Country (2021-2026) & (US$ Million) Table 139. Middle East and Africa Cabozantinib Tablets Market Share by Country (2021-2026) Table 140. Middle East and Africa Cabozantinib Tablets Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Middle East and Africa Cabozantinib Tablets Market Share Forecast by Country (2027-2032) Table 142. Key Raw Materials Table 143. Raw Materials Key Suppliers Table 144. Cabozantinib Tablets Distributors List Table 145. Cabozantinib Tablets Customers List Table 146. Research Programs/Design for This Report Table 147. Authors List of This Report Table 148. Secondary Sources Table 149. Primary Sources List of Figures Figure 1. Cabozantinib Tablets Image Figure 2. Global Cabozantinib Tablets Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cabozantinib Tablets Market Size (2021-2032) & (US$ Million) Figure 4. Global Cabozantinib Tablets Sales (2021-2032) & (K Units) Figure 5. 60mg per Tablet Image Figure 6. Global 60mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 7. 40mg per Tablet Image Figure 8. Global 40mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 9. 20mg per Tablet Image Figure 10. Global 20mg per Tablet Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Cabozantinib Tablets Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Cabozantinib Tablets Market Share by Type 2025 VS 2032 Figure 13. North America Cabozantinib Tablets Sales Market Share in Volume by Type in 2025 Figure 14. North America Cabozantinib Tablets Sales Market Share in Value by Type in 2025 Figure 15. Europe Cabozantinib Tablets Sales Market Share in Volume by Type in 2025 Figure 16. Europe Cabozantinib Tablets Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Cabozantinib Tablets Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Cabozantinib Tablets Sales Market Share in Value by Type in 2025 Figure 19. Latin America Cabozantinib Tablets Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Cabozantinib Tablets Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Cabozantinib Tablets Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Cabozantinib Tablets Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Cabozantinib Tablets Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Medullary Thyroid Cancer Image Figure 26. Global Medullary Thyroid Cancer Sales YoY Growth (2021-2032) & (K Units) Figure 27. Renal Cell Carcinoma Image Figure 28. Global Renal Cell Carcinoma Sales YoY Growth (2021-2032) & (K Units) Figure 29. Hepatocellular Carcinoma Image Figure 30. Global Hepatocellular Carcinoma Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Cabozantinib Tablets Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Cabozantinib Tablets Market Share by Application 2025 VS 2032 Figure 33. North America Cabozantinib Tablets Sales Market Share in Volume by Application in 2025 Figure 34. North America Cabozantinib Tablets Sales Market Share in Value by Application in 2025 Figure 35. Europe Cabozantinib Tablets Sales Market Share in Volume by Application in 2025 Figure 36. Europe Cabozantinib Tablets Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Cabozantinib Tablets Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Cabozantinib Tablets Sales Market Share in Value by Application in 2025 Figure 39. Latin America Cabozantinib Tablets Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Cabozantinib Tablets Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Cabozantinib Tablets Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Cabozantinib Tablets Sales Market Share in Value by Application in 2025 Figure 43. North America Cabozantinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Cabozantinib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Cabozantinib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Cabozantinib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Cabozantinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Cabozantinib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Cabozantinib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Cabozantinib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Cabozantinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Cabozantinib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Cabozantinib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Cabozantinib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Cabozantinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Cabozantinib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Cabozantinib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Cabozantinib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Cabozantinib Tablets Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Cabozantinib Tablets Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Cabozantinib Tablets Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Cabozantinib Tablets Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Cabozantinib Tablets Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Cabozantinib Tablets Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • 60mg per Tablet
  • 40mg per Tablet
  • 20mg per Tablet
Applications
  • Medullary Thyroid Cancer
  • Renal Cell Carcinoma
  • Hepatocellular Carcinoma
Companies covered
  • Cipla
  • Natco Pharma
  • Exelixis
  • Drug International

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cabozantinib Tablets Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cabozantinib Tablets Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cabozantinib Tablets Market by Type
  6. 1.3.1 60mg per Tablet
  7. 1.3.2 40mg per Tablet
  8. 1.3.3 20mg per Tablet
  9. 1.4 Global Cabozantinib Tablets Market Size by Type
  10. 1.4.1 Global Cabozantinib Tablets Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Cabozantinib Tablets Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Cabozantinib Tablets Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Cabozantinib Tablets Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Cabozantinib Tablets Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Cabozantinib Tablets Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Cabozantinib Tablets Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Cabozantinib Tablets Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cabozantinib Tablets Industry Trends
  2. 2.2 Cabozantinib Tablets Industry Drivers
  3. 2.3 Cabozantinib Tablets Industry Opportunities and Challenges
  4. 2.4 Cabozantinib Tablets Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cabozantinib Tablets Revenue (2021-2026)
  2. 3.2 Global Top Players by Cabozantinib Tablets Sales (2021-2026)
  3. 3.3 Global Top Players by Cabozantinib Tablets Price (2021-2026)
  4. 3.4 Global Cabozantinib Tablets Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cabozantinib Tablets Major Company Production Sites & Headquarters
  6. 3.6 Global Cabozantinib Tablets Company, Product Type & Application
  7. 3.7 Global Cabozantinib Tablets Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cabozantinib Tablets Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cabozantinib Tablets Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cabozantinib Tablets Tier 1, Tier 2, and Tier 3
4 Cabozantinib Tablets Regional Status and Outlook
  1. 4.1 Global Cabozantinib Tablets Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cabozantinib Tablets Historic Market Size by Region
  3. 4.2.1 Global Cabozantinib Tablets Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cabozantinib Tablets Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cabozantinib Tablets Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cabozantinib Tablets Forecasted Market Size by Region
  7. 4.3.1 Global Cabozantinib Tablets Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cabozantinib Tablets Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cabozantinib Tablets Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cabozantinib Tablets by Application
  1. 5.1 Cabozantinib Tablets Market by Application
  2. 5.1.1 Medullary Thyroid Cancer
  3. 5.1.2 Renal Cell Carcinoma
  4. 5.1.3 Hepatocellular Carcinoma
  5. 5.2 Global Cabozantinib Tablets Market Size by Application
  6. 5.2.1 Global Cabozantinib Tablets Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Cabozantinib Tablets Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Cabozantinib Tablets Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Cabozantinib Tablets Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Cabozantinib Tablets Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Cabozantinib Tablets Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Cabozantinib Tablets Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Cabozantinib Tablets Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Cipla
  2. 6.1.1 Cipla Company Information
  3. 6.1.2 Cipla Business Overview
  4. 6.1.3 Cipla Cabozantinib Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Cipla Cabozantinib Tablets Product Portfolio
  6. 6.1.5 Cipla Recent Developments
  7. 6.2 Natco Pharma
  8. 6.2.1 Natco Pharma Company Information
  9. 6.2.2 Natco Pharma Business Overview
  10. 6.2.3 Natco Pharma Cabozantinib Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Natco Pharma Cabozantinib Tablets Product Portfolio
  12. 6.2.5 Natco Pharma Recent Developments
  13. 6.3 Exelixis
  14. 6.3.1 Exelixis Company Information
  15. 6.3.2 Exelixis Business Overview
  16. 6.3.3 Exelixis Cabozantinib Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Exelixis Cabozantinib Tablets Product Portfolio
  18. 6.3.5 Exelixis Recent Developments
  19. 6.4 Drug International
  20. 6.4.1 Drug International Company Information
  21. 6.4.2 Drug International Business Overview
  22. 6.4.3 Drug International Cabozantinib Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Drug International Cabozantinib Tablets Product Portfolio
  24. 6.4.5 Drug International Recent Developments
7 North America by Country
  1. 7.1 North America Cabozantinib Tablets Sales by Country
  2. 7.1.1 North America Cabozantinib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cabozantinib Tablets Sales by Country (2021-2026)
  4. 7.1.3 North America Cabozantinib Tablets Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cabozantinib Tablets Market Size by Country
  6. 7.2.1 North America Cabozantinib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cabozantinib Tablets Market Size by Country (2021-2026)
  8. 7.2.3 North America Cabozantinib Tablets Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cabozantinib Tablets Sales by Country
  2. 8.1.1 Europe Cabozantinib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cabozantinib Tablets Sales by Country (2021-2026)
  4. 8.1.3 Europe Cabozantinib Tablets Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cabozantinib Tablets Market Size by Country
  6. 8.2.1 Europe Cabozantinib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cabozantinib Tablets Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cabozantinib Tablets Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cabozantinib Tablets Sales by Country
  2. 9.1.1 Asia-Pacific Cabozantinib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cabozantinib Tablets Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cabozantinib Tablets Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cabozantinib Tablets Market Size by Country
  6. 9.2.1 Asia-Pacific Cabozantinib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cabozantinib Tablets Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cabozantinib Tablets Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cabozantinib Tablets Sales by Country
  2. 10.1.1 South America Cabozantinib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cabozantinib Tablets Sales by Country (2021-2026)
  4. 10.1.3 South America Cabozantinib Tablets Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cabozantinib Tablets Market Size by Country
  6. 10.2.1 South America Cabozantinib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cabozantinib Tablets Market Size by Country (2021-2026)
  8. 10.2.3 South America Cabozantinib Tablets Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cabozantinib Tablets Sales by Country
  2. 11.1.1 Middle East and Africa Cabozantinib Tablets Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cabozantinib Tablets Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cabozantinib Tablets Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cabozantinib Tablets Market Size by Country
  6. 11.2.1 Middle East and Africa Cabozantinib Tablets Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cabozantinib Tablets Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cabozantinib Tablets Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cabozantinib Tablets Value Chain Analysis
  2. 12.1.1 Cabozantinib Tablets Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cabozantinib Tablets Production Mode & Process
  7. 12.2 Cabozantinib Tablets Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cabozantinib Tablets Distributors
  10. 12.2.3 Cabozantinib Tablets Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst